Institutional Readiness for management of Vaxzevria Vaccine in Trusts

Mark Cheeseman, Professional Lead for Medicines Information, Midlands & East, Midlands and East Medicines Advice Service (East site)Published Last updated See all updates

Must read guidance for Chief Pharmacists and others in Trusts on the Vaxzevria Vaccine.

Purpose

The attachment below outlines the medicines management responsibilities of Chief Pharmacists for Mass Vaccination in Hub and Non-Hub Trust sites, and provides supporting guidance and resources in relation to:

  • Safe storage and distribution, including temperature controlled storage, stock control and reporting vaccine usage to UK Health Security Agency (UKHSA)
  • Oversight of vaccine handling and preparation

The document aims to promote consistency of practice by providing flow diagrams outlining a stepwise approach to implementing Pharmacy processes to receive, store and issue vaccines, and to oversee vaccine handling processes by clinical staff.

Attachments

Other handling content for Trusts

Other COVID-19 vaccines resources

Change history

  1. Removal of reference to Regulation 174 product and updated throughout to reflect change in name for the licensed product (Vaxzevria).
  1. Reference to Public Health England or PHE in the purpose section on the page removed.
  1. Reference to Public Health England or PHE amended to UK Health Security Agency or UKHSA, and removed reference to patient factsheets initially only being available electronically.
  1. Section on mutual aid and transfer of COVID-19 vaccine between hospital hubs, vaccination centres and local vaccination services added.
  1. Link to NHSE position statement about microbial risk associated with movement of punctured vials added.
  1. Broken hyperlinks updated.
  1. Addition of new link to IT Policy document on SPS website.
  2. Wording amended to clarify that outer packaging must be disposed of as confidential waste.
  1. Amended link for to best practice for storing COVID-19 vaccines in the refrigerator
  1. Minor amendment to wording linking to V1 IT Policy and removal of 'agent to be confirmed' for antiviral disinfectant.
  1. Quantity of vials in each carton corrected. Page numbers amended.
  1. Included hyperlink to ‘Deployment of COVID-19 Vaccine Oxford/AstraZeneca: implications for governance, handling and preparation of vaccines’ letter
  1. Published